Abstract:Stroke is a serious, adverse neurological event and the third leading cause of death and disability worldwide. Most strokes are caused by a block in cerebral blood flow, resulting in neurological deficits through the death of brain tissue. Recombinant tissue plasminogen activator (rt-PA) is currently the only immediate treatment medication for stroke. The goal of rt-PA administration is to reduce the thrombus and/or embolism via thrombolysis; however, the administration of rt-PA must occur within a very short therapeutic timeframe (3 h to 6 h) after symptom onset. Components of the pathological mechanisms involved in ischemic stroke can be used as potential biomarkers in current treatment. However, none are currently under investigation in clinical trials; thus, further studies investigating biomarkers are needed. After ischemic stroke, microglial cells can be activated and release inflammatory cytokines. These cytokines lead to severe neurotoxicity via the overactivation of microglia in prolonged and lasting insults such as stroke. Thus, the balanced regulation of microglial activation may be necessary for therapy. Stem cell therapy is a promising clinical treatment strategy for ischemic stroke. Stem cells can increase the functional recovery of damaged tissue after post-ischemic stroke through various mechanisms including the secretion of neurotrophic factors, immunomodulation, the stimulation of endogenous neurogenesis, and neovascularization. To investigate the use of stem cell therapy for neurological diseases in preclinical studies, however, it is important to develop imaging technologies that are able to evaluate disease progression and to “chase” (i.e., track or monitor) transplanted stem cells in recipients. Imaging technology development is rapidly advancing, and more sensitive techniques, such as the invasive and non-invasive multimodal techniques, are under development. Here, we summarize the potential risk factors and biomarker treatment strategies, stem cell-based therapy and emerging multimodal imaging techniques in the context of stroke. This current review provides a conceptual framework for considering the therapeutic targets and directions for the treatment of brain dysfunctions, with a particular focus on ischemic stroke.

Optimizing stent retrievers for mechanical enhancement and in vitro testing in acute ischemic stroke models

In vitro models for the experimental evaluation of mechanical thrombectomy devices in acute ischemic stroke

Simulation of Stent Retriever Thrombectomy in Acute Ischemic Stroke by Finite Element Analysis

Abstract TP214: In-Silico versus In-Vitro Evaluation of a New Stent-Retriever Design: A Novel Approach to Pre-Clinical Device Development

An in Vitro Porcine Model Evaluating a Novel Stent Retriever for Thrombectomy of the Common Carotid Artery

Clinical Effect Observations of Stent-like Retrievers in Ischemic Stroke Patients with Mechanical Thrombectomy

Mechanical Thrombectomy by Solitaire Stent for Treating Acute Ischemic Stroke: A Prospective Cohort Study

Advancing stroke therapy: innovative approaches with stem cell-derived extracellular vesicles

Overview of Mechanical Thrombectomy Techniques

New mechanisms-based therapies in acute ischaemic stroke

A direct aspiration first-pass technique (ADAPT) versus stent retriever for acute ischemic stroke (AIS): a systematic review and meta-analysis

Comparison of Four Food and Drug Administration-Approved Mechanical Thrombectomy Devices for Acute Ischemic Stroke: A Network Meta-Analysis.

Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke

Applicability assessment of a stent-retriever thrombectomy finite-element model

Endovascular Treatment For Acute Ischemic Stroke: Updates And Future Implications

The Important Role of Manual Aspiration Through the Guiding Catheter During Repeated Solitaire Mechanical Thrombectomy in Acute Ischemic Stroke

Multiphase Adjuvant Neuroprotection: A Novel Paradigm For Improving Acute Ischemic Stroke Outcomes

Clinical study of endovascular treatment of acute ischemic stroke with combinedmechanical thrombectomy, intra-arterial thrombolysis and stenting

Prospects of Therapeutic Target and Directions for Ischemic Stroke

Advances in nanoparticle-based therapeutics for ischemic stroke: Enhancing drug delivery and efficacy

Optimizing Tigertriever adjustable stentriever technique: Operators' experience